The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases

R. Westhovens, F. De Keyser, F.H.J. van den Hoogen, B. Hellmich, C.G. Kallenberg, B. Lauwerys, P. Schenk, D.J. Abraham, B.N. Lambrecht, J.C. Grutters, M. Demedts, and the co-workers of working group 1

Source: Eur Respir Mon; 2006: 34: 1–26
Disease area: Interstitial lung diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Westhovens, F. De Keyser, F.H.J. van den Hoogen, B. Hellmich, C.G. Kallenberg, B. Lauwerys, P. Schenk, D.J. Abraham, B.N. Lambrecht, J.C. Grutters, M. Demedts, and the co-workers of working group 1. The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases. Eur Respir Mon; 2006: 34: 1–26

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27
Year: 2005

Features of pulmonary involvement in patients with diffuse connective tissue diseases
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011


Interstitial lung disease with autoimmune features
Source: Eur Respir Mon 2011; 54: 104-117
Year: 2011


Clinico-radiological profile of connective tissue diseases related interstitial lung diseases
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Features of pulmonary involvement in patients with diffuse connective tissue diseases depending on a nosological form
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011


Chemical exposure triggering connective tissue disease with lung involvement
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001



Morphologic evaluation of lung in a scleroderma-like rabbit model
Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease
Year: 2006


Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013



Interstitial lung disease in patients with connective tissue diseases - a report of 3 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 668s
Year: 2004

What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Source: Eur Respir J 2009; 33: 882-896
Year: 2009



Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy},
Source: Eur Respir J 2012; 40: 641-648
Year: 2012



Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases
Source: International Congress 2017 – Rare diseases
Year: 2017


Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013